arrow
H

Hilary Wilkinson

Merck & Co. Inc.
H指数:27
被引数:3,481

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Suppression of Huntington’s Disease Somatic Instability by Transcriptional Repression and Direct CAG Repeat Binding

通过转录抑制和直接CAG重复序列结合抑制亨廷顿病体细胞不稳定性

2025-11-140
OAAI
Orthosteric inhibition of MutSβ ATPase function: First disclosure of MSH3-bound small molecule inhibitors

MutSβ ATP酶功能的正构位点抑制:MSH3结合小分子抑制剂的首次披露

2025-07-030
PRE
Developing HDAC4-Selective Protein Degraders To Investigate the Role of HDAC4 in Huntington's Disease Pathology

开发HDAC4-Selective蛋白降解剂以研究HDAC4在亨廷顿病病理学中的作用

2022-09-1319
OAAI
DNA methylation study of Huntington's disease and motor progression in patients and in animal models
2020-09-1047
OAAI
Increased Muscle Force Production and Bone Mineral Density in ActRIIB-Fc-Treated Mature Rodents
2013-03-2261
OAAI
Systems analysis of eleven rodent disease models reveals an inflammatome signature and key drivers
2012-07-17122
OAAI
Identification of small molecule estrogen-related receptor α-specific antagonists and homology modeling to predict the molecular determinants as the basis for selectivity over ERRβ and ERRγ

鉴定小分子雌激素相关受体 α 特异性拮抗剂和同源建模以预测分子决定因素作为对err β 和err γ 选择性的基础

2008-08-1515
PREAI
Frespaciguat (MK-5475): A Novel Inhaled Soluble Guanylate Cyclase Stimulator for Pulmonary Hypertension Associated with COPD

Frespaciguat(MK-5475):一种用于COPD相关肺动脉高压的新型吸入性可溶性鸟苷酸环化酶刺激剂

0
PRE